Researchers have worked out the exact function of an enzyme that is critical for normal muscle structure and is involved in several muscular dystrophies. The findings could be used to develop ...

Significant improvement was seen in motor function for patients with spinal muscular atrophy receiving apitegromab vs placebo.

Human protein improves muscle function of muscular dystrophy mice Date: December 29, 2010 Source: Brown University Summary: A novel potential therapy based on a natural human protein significantly ...

Viltepso, an injection treatment for Duchenne muscular dystrophy in patients with a confirmed mutation, demonstrated a statistically significant benefit for motor function in open-label extension ...

Treatment with nusinersen was linked to increased motor function and reduction of the neurodegenerative biomarker neurofilament light chain in children with spinal muscular atrophy, according to ...

Skeletal muscle function was determined by stimulating the ulnar nerve at the left wrist and measuring the force of isometric contractions of the abductor pollicis muscle using a stimulus ...

A team of Vanderbilt researchers has developed a wirelessly activated device that mimics the wavelike muscular function in the esophagus and small intestine responsible for transporting food and ...

Spinal muscular atrophy (SMA) is caused by reduced amounts of the ubiquitously expressed survival motor neuron protein (SMN). SMN functions in RNA metabolism, but the question of which aspect of ...

Some patients with later-onset spinal muscular atrophy (SMA) type 2 and type 3 had improved motor function when the investigational monoclonal antibody apitegromab was added to their treatment ...

Until recently, babies and children with spinal muscular atrophy (SMA) lacked any type of treatment capable of stopping the neuromuscular disease from progressing. In SMA, damaged motor neurons in ...